Effectiveness of oral acyclovir and 1 2 deoxy 2 fluoro beta d arabinofuranosyl thymine fmau against hsv stromal keratitis in balb c mice
Seedor, J.A.; Schinazi, R.F.; Stulting, R.D.
IOVS Investigative Ophthalmology and Visual Science 29: 443
1988
ISSN/ISBN: 0146-0404 Accession: 028196316
Full Text Article emailed within 1 workday: $29.90
Related References
Schinazi, R.F.; Peters, J.; Sokol, M.K.; Nahmias, A.J. 1983: Therapeutic activities of 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo cytosine and 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo thymine alone and in combination with acyclovir and vidarabine in mice infected intra cerebrally with herpes simplex virus Antimicrobial Agents and Chemotherapy 24(1): 95-103Tann, C.H.; Brodfuehrer, P.R.; Brundidge, S.P.; Sapino Jr., C.; Howell, H.G. 1985: Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (.beta.-FIAU) and 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)thymine (.beta.-FMAU) The Journal of Organic Chemistry 50(19): 3644-3647
Schinazi, R.F.; Peters, J.; Sokol, M.K.; Nahmias, A.J. 1983: Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus Antimicrobial Agents and ChemoTherapy 24(1): 95-103
Samuelsson, L.; Langstrom, B. 2003: Synthesis of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-(methyl-11C)thymine ((11C)FMAU) via a Stille cross-coupling reaction with (11C)methyl iodide Journal of Labelled Compounds and Radiopharmaceuticals 46(3): 263-272
Seedor, J.A.; Schinazi, R.F.; Scott, R.T.; Yao, X.; Stulting, R.D.; Nahmias, A.J. 1986: Potent activity of topical 1 2 deoxy 2 fluoro beta d arabinofuranosylthymine against stromal keratitis in balb c mice IOVS Investigative Ophthalmology and Visual Science 27(3): 117
Philips, F.S.; Feinberg, A.; Chou, T.C.; Vidal, P.M.; Su, T.L.; Watanabe, K.A.; Fox, J.J. 1983: Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine Cancer Research 43(8): 3619-3627
Wiegand, R.; Wu, J.; Shields, A.F.; Lorusso, P.; Li, J. 2012: Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 891-892: 64-70
Wright, J.D.; Ma, T.; Chu, C.K.; Boudinot, F.D. 1995: Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats Pharmaceutical Research 12(9): 1350-1353
Mu, F.; Mangner, T.J.; Anderson, L.W.; Klecker, R.W.; Shields, A.F. 2003: Simplified synthesis of 2-deoxy-2- fluoro-beta-D-arabinofuranosyl uracils FAU, FMAU, FBAU, FIAU Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S163
Philips, F.S.; Feinberg, A.; Tingchao, C.H.O.U.; Vidal, P.M.; Tsannlong, S.U.; Watanabe, K.A.; Fox, J.J. 1983: Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine - Distribution, métabolisme et excrétion de la 1-(2-fluoro-2-désoxy-β-D-arabinofuranosyl) thymine et de la 1-(2-fluoro-2-désoxy-β-D-arabinofuranosyl)-5-iodocytosine Cancer Research (Baltimore) 43(8): 3619-3627
Mangner, T.J.; Klecker, R.W.; Anderson, L.; Shields, A.F. 2003: Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU Nuclear Medicine and Biology 30(3): 215-224
Stuhmiller, L.M.; Hostetler, K.Y.; King, D.H. 1990: Synthesis and antiviral activity of phospholipid derivatives of 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 iodouracil fiau and 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 iodocytidine fiac Abstracts of Papers American Chemical Society 200(1-2): MEDI 134
Tehrani, O.S.; Muzik, O.; Heilbrun, L.K.; Douglas, K.A.; Lawhorn-Crews, J.M.; Sun, H.; Mangner, T.J.; Shields, A.F. 2007: Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 48(9): 1436-1441
Fanucchi, M.P.; Leyland-Jones, B.; Young, C.W.; Burchenal, J.H.; Watanabe, K.A.; Fox, J.J. 1985: Phase i trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) Cancer Treatment Reports 69(1): 55-59
Pankiewicz, K.W.; Nawrot, B.; Gadler, H.; Price, R.W.; Watanabe, K.A. 1987: Nucleosides. 146. 1-Methyl-5-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil, the C-nucleoside isostere of the potent antiviral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)thymine (FMAU). Studies directed toward the synthesis of 2'-deoxy-2'-substituted arabino nucleosides. 6 Journal of Medicinal Chemistry 30(12): 2314-2316
Ijichi, K.; Mitamura, K.; Ida, S.; Machida, H.; Shimada, K. 1997: Comparison of antiviral effects of mismatched double-stranded RNA and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyl-uracil (D-FMAU) against duck hepatitis B virus in vitro Antiviral Chemistry and Chemotherapy 8(6): 537-540
Nimmagadda, S.; Mangner, T.J.; Lawhorn-Crews, J.M.; Haberkorn, U.; Shields, A.F. 2009: Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil) European Journal of Nuclear Medicine and Molecular Imaging 36(12): 1987-1993
Dziewiszek K.; Su T L.; Watanabe K.A. 1990: Derivatives of 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 phenyluracil and 1 2 deoxy 2 fluoro b d arabinofuranosyl 5 benzyluracil synthesis and some biological properties Abstracts of Papers American Chemical Society 200(1-2): MEDI 136
Sapse, A.M.; Snyder, G. 1985: Ab initio studies of the antiviral drug 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl) thymine Cancer Investigation 3(2): 115-121
Abbruzzese, J.L.; Schmidt, S.; Raber, M.N.; Levy, J.K.; Castellanos, A.M.; Legha, S.S.; Krakoff, I.H. 1989: Phase i trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity Investigational new Drugs 7(2-3): 195-201